SCHEMBL22985546

SCHEMBL22985546

Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C)cc4)ccc2n3-c2ccc(-c3ccc(C(F)(F)F)cc3C#N)cc2-c2c(C#N)cccc2-n2c3ccc(-c4ccc(C)cc4)cc3c3cc(-c4ccc(C)cc4)ccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.38
ALOX5AP P20292 1/20 0.38
FEN1 P39748 1/20 0.38
XDH P47989 2/20 0.36
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ICMT O60725 1/20 0.34
HCRTR1 O43613 1/20 0.30
HCRTR2 O43614 1/20 0.30
RAF1 P04049 1/20 0.30
BRAF P15056 1/20 0.30
MAOA P21397 1/20 0.30
NPC1 O15118 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
CYP2C19 P33261 1/20 0.30
RAB9A P51151 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRG2 P18507 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985630 0.97 ALOX5AP (0.35) ARALOX5APFEN1XDHTSHR
SCHEMBL22985521 0.94 ALOX5AP (0.39) ARALOX5APFEN1XDHTSHR
SCHEMBL22985621 0.94 AR (0.42) ARALOX5APFEN1XDHTSHR
SCHEMBL22985665 0.94 ALOX5AP (0.37) ARALOX5APFEN1XDHTSHR
SCHEMBL20848738 0.93 AR (0.41) ARALOX5APFEN1XDHTSHR
SCHEMBL22985667 0.93 ALOX5AP (0.36) ARALOX5APFEN1XDHTSHR
SCHEMBL22985392 0.93 ALOX5AP (0.39) ARALOX5APFEN1XDHTSHR
SCHEMBL22985668 0.92 KIF11 (0.38) ALOX5APFEN1XDHTSHRSMN1; SMN2
SCHEMBL22985629 0.92 ALOX5AP (0.41) ARALOX5APFEN1XDHTSHR
SCHEMBL22985511 0.91 ALOX5AP (0.36) ARALOX5APFEN1XDHTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 AR 3541/4885ALOX5AP 2567/4885FEN1 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.